Besides, the GSK-3β inhibitors, AR-A014418, AZD2858, AZD1080, as well as the GSK-3β and acetylcholinesterase (AchE) dual inhibitor 13, demonstrated anti-AD effects in AD animals26,37–39 (Figure 1(B)). This evidence concerns the gene ACHE and Alzheimer disease.